- Represents A New Surgical Assurance Platform
for Predictable Surgery and Patient Benefit –
- Mazor to webcast Analyst Day Presentations
-
Mazor Robotics Ltd. (TASE: MZOR; NASDAQGM: MZOR), a pioneer and
a leader in the field of surgical guidance systems, today unveiled
Mazor X, a transformative guidance platform for spine surgeries.
The Mazor X was developed with the goal of enhancing predictability
and patient benefit, through the combination of analytical tools,
multiple-source data, precision guidance, optical tracking,
intra-op verification, and connectivity technologies.
The Company will commercially launch the FDA-cleared Mazor X
platform during the North American Spine Society (NASS) annual
meeting which will be held in Boston, Massachusetts, this October.
Mazor recently signed a commercial co-promotion and co-development
agreement with Medtronic. As part of the agreement, Medtronic has
already placed a purchase order for 15 Mazor X systems.
“Mazor X is the culmination of a multi-year development effort
to proactively address our target market, surgeon and patient needs
for today’s reimbursement environment, by applying
multi-disciplinary principles to achieve a Surgical Assurance
platform,” commented Ori Hadomi, Chief Executive Officer. “Our
pioneering experience in guidance technology, which has been used
by hundreds of surgeons to place over 100,000 guided spine
implants, has been leveraged in the development of the Mazor X
system.”
“The Mazor X platform expands the field of spine surgery from
trajectory guidance to assisting surgeons with a total patient
treatment strategy. Following our recently formed partnership with
Medtronic and the increased market access it provides us, the
launch of the Mazor X positions us for accelerated growth and long
term leadership in the spine market,” concluded Mr. Hadomi.
“We've now got a platform that could help us be more precise,
more efficient, and reduce the overall risk rate of spinal
surgery," said Dr. Isador Lieberman from Plano, Texas. “These tools
are facilitating the plan and its execution with precision.”
“In my opinion, it [Mazor X] will be the standard of care, no
doubt about it,” Dr. Dennis Devito from Atlanta, Georgia added.
“This goes beyond just placing an implant. We’re looking at how the
whole procedure works."
The Mazor X, which has been clinically validated in a variety of
cases, represents a significant milestone in Mazor’s development.
Surgical Assurance is provided by the Mazor X via three main
coordinated processes:
- Pre-Operative Analytics: A suite of
software-based sophisticated tools designed to pre-operatively
assess spinal alignment and implement full surgical planning,
facilitating a total patient treatment strategy. A key component of
Pre-Op Analytics, the X-Align* module, is a combination of
biomechanical logic and virtual surgical tools with computerized
alignment calculations, intended to streamline the process of
creating a holistic alignment plan for each patient.
- Intra-Operative Guidance: Utilizing
precision mechanics and a bed-attached, bone-mounted surgical arm
to guide surgical tools and synergistic implants* according to the
Pre-Op Analytics. Coupled with innovative tracking* and imaging,
Intra-operative Guidance effects predictable execution of the
surgical plan.
- Real-Time 3D Verification*: The Mazor X
System's real-time verification allows surgeons to close the
surgical loop and confirm - execution and reconciliation of the
surgical plan using proprietary 2D fluoroscopy-based technology,
visual tracking*, or intraoperative imaging systems.
*Pending FDA clearance
Together with surgeon skill and real-time feedback from multiple
data sources in the operating room, these processes form a Surgical
Assurance platform to benefit patients and surgeons.
In May 2016, Mazor entered into two strategic agreements with
Medtronic, the terms of which were disclosed in an announcement
issued on May 18, 2016.
(http://www.mazorrobotics.com/mazor-robotics-signs-strategic-commercial-and-investment-agreements-with-medtronic-a-global-leader-in-spine-technologies-and-solutions/)
In accordance with the agreements, the unveiling of the Mazor X
system is an operational milestone which, subject to satisfaction
of certain other customary conditions to closing as stipulated in
the investment agreement, triggers the second tranche of equity
investment by Medtronic in Mazor.
Analyst Day webcast
Mazor is hosting an Analyst Day in New York City this morning,
July 12, 2016, beginning at 8:30am ET (3:30pm IST). Senior Mazor
management, key clinical opinion leader and the Vice President and
General Manager for Medtronic’s Neurosurgery business will
introduce the Mazor X, including a live product demo and clinical
experience, and will present a number of key topics including
accelerated growth platforms and strategies, new clinical data,
long term financial models and Q&A. A webcast with accompanying
slides will be available on the Investor Relations page of the
Company's website
at http://www.mazorrobotics.com/investor-relations/. A replay
of the webcast and a video of the event will also be available on
the Company’s website following the event.
About Mazor Robotics
Mazor Robotics (TASE: MZOR; NASDAQGM: MZOR) believes in healing
through innovation by developing and introducing revolutionary
technologies and products aimed at redefining the gold standard of
quality care. Mazor Robotics Guidance Systems enable surgeons
to conduct spine and brain procedures in a more accurate and secure
manner. For more information, please visit
www.MazorRobotics.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
and other securities laws. Any statements in this release about
future expectations, plans or prospects for the Company, including
without limitation, statements regarding the launch of Mazor X, the
purchase of Mazor X systems, the benefits of Mazor X and its
becoming the standard of care, the second tranche of investment by
Medtronic in Mazor, and other statements containing the words
“believes,” “anticipates,” “plans,” “expects,” “will” and similar
expressions are forward-looking statements. These statements are
only predictions based on Mazor's current expectations and
projections about future events. There are important factors that
could cause Mazor's actual results, level of activity, performance
or achievements to differ materially from the results, level of
activity, performance or achievements expressed or implied by the
forward-looking statements. Those factors include, but are not
limited to, the impact of general economic conditions, competitive
products, product demand and market acceptance risks, reliance on
key strategic alliances, fluctuations in operating results, and
other factors indicated in Mazor's filings with the Securities and
Exchange Commission (SEC) including those discussed under the
heading "Risk Factors" in Mazor’s annual report on Form 20-F filed
with the SEC on May 2, 2016 and in subsequent filings with the SEC.
For more details, refer to Mazor's SEC filings. Mazor undertakes no
obligation to update forward-looking statements to reflect
subsequent occurring events or circumstances, or to changes in our
expectations, except as may be required by law.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160712005567/en/
EVC GroupMichael Polyviou,
732.232.6914mpolyviou@evcgroup.comorInvestorsDoug Sherk,
415.652.9100dsherk@evcgroup.comorMediaDavid Schemelia,
609.468.9325dave@evcgroup.com
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Aug 2024 to Sep 2024
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Sep 2023 to Sep 2024